Alba L Montoya
Overview
Explore the profile of Alba L Montoya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
You W, Montoya A, Dana S, Franzini R, Steegborn C
ChemMedChem
. 2024 Jun;
19(20):e202400273.
PMID: 38940296
Sirtuin 6 (Sirt6), an NAD-dependent deacylase, has emerged as a promising target for aging-related diseases and cancer. Advancing the medicinal chemistry of Sirt6 modulators is crucial for the development of...
2.
Montoya A, Gil E, Vinales I, Estevao I, Taboada P, Torrico M, et al.
Carbohydr Res
. 2024 Jan;
536:109015.
PMID: 38198982
The protozoan parasite Leishmania (Viannia) braziliensis is among Latin America's most widespread Leishmania species and is responsible for tegumentary leishmaniasis (TL). This disease has multiple clinical presentations, with cutaneous leishmaniasis...
3.
Weigel 3rd W, Montoya A, Franzini R
J Chem Inf Model
. 2023 Jul;
63(15):4641-4653.
PMID: 37493573
DNA-encoded libraries (DELs) are widely used in the discovery of drug candidates, and understanding their design principles is critical for accessing better libraries. Most DELs are combinatorial in nature and...
4.
Montoya A, Glavatskikh M, Halverson B, Yuen L, Schuler H, Kireev D, et al.
Eur J Med Chem
. 2022 Dec;
246:114980.
PMID: 36495630
DNA-encoded chemical libraries (DECLs) interrogate the interactions of a target of interest with vast numbers of molecules. DECLs hence provide abundant information about the chemical ligand space for therapeutic targets,...
5.
Montoya A, Carvajal E, Ortega-Rodriguez U, Estevao I, Ashmus R, Jankuru S, et al.
Molecules
. 2022 Sep;
27(17).
PMID: 36080480
Chagas disease (CD) is caused by the parasite and affects 6-7 million people worldwide. The diagnosis is still challenging, due to extensive parasite diversity encompassing seven genotypes (TcI-VI and Tcbat)...
6.
Viana S, Montoya A, Carvalho A, de Mendonca B, Portillo S, Olivas J, et al.
Emerg Microbes Infect
. 2022 Aug;
11(1):2147-2159.
PMID: 36039908
American tegumentary leishmaniasis (TL) caused by is characterized by a spectrum of clinical presentations, ranging from localized cutaneous ulcers (CL), mucosal (ML), or disseminated (DL) disease, to a subclinical (SC)...
7.
Montoya A, Gil E, Heydemann E, Estevao I, Luna B, Ellis C, et al.
Molecules
. 2022 Jan;
27(2).
PMID: 35056727
Chagas disease (CD) can be accurately diagnosed by detecting in patients' blood using polymerase chain reaction (PCR). However, parasite-derived biomarkers are of great interest for the serological diagnosis and early...
8.
Montoya A, Austin V, Portillo S, Vinales I, Ashmus R, Estevao I, et al.
JACS Au
. 2021 Sep;
1(8):1275-1287.
PMID: 34467365
All healthy humans have high levels of natural anti-α-galactosyl (α-Gal) antibodies (elicited by yet uncharacterized glycotopes), which may play important roles in immunoglycomics: (a) potential protection against certain parasitic and...
9.
Ortega-Rodriguez U, Portillo S, Ashmus R, Duran J, Schocker N, Iniguez E, et al.
Methods Mol Biol
. 2019 Mar;
1955:287-308.
PMID: 30868536
Chagas disease (ChD), caused by the protozoan parasite Trypanosoma cruzi, affects millions of people worldwide. Chemotherapy is restricted to two drugs, which are partially effective and may cause severe side...
10.
Subramaniam K, Austin V, Schocker N, Montoya A, Anderson M, Ashmus R, et al.
Parasitology
. 2018 Jun;
145(13):1758-1764.
PMID: 29898796
Outbreaks of Old World cutaneous leishmaniasis (CL) have significantly increased due to the conflicts in the Middle East, with most of the cases occurring in resource-limited areas such as refugee...